Elevated thyroid-stimulating hormone (TSH) levels have been associated with a reduced risk of genetically predicted prostatitis [18]. This relationship can be explained theoretically, as primary hypothyroidism may lead to hypogonadotropic hypogonadism through hypersecretion of prolactin. The gene discussed is PRL; the disease is male reproductive organ cancer.